Skip to main content
Erschienen in: International Cancer Conference Journal 1/2019

24.09.2018 | Case report

Hepatocellular carcinoma producing granulocyte colony-stimulating factor: diagnosis and treatment

verfasst von: Yuzuru Sakamoto, Toshiya Kamiyama, Hideki Yokoo, Shingo Shimada, Takahiro Einama, Kenji Wakayama, Tatsuya Orimo, Hirofumi Kamachi, Tomoaki Naka, Tomoko Mitsuhashi, Akinobu Taketomi

Erschienen in: International Cancer Conference Journal | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Granulocyte colony-stimulating factor (G-CSF) is a naturally occurring glycoprotein that is synthesized by stromal cells in bone marrow. Several cases of G-CSF-producing malignant tumors in various organs have been reported, but it is extremely rare in hepatocellular carcinoma (HCC). Here, we report a rare case of HCC producing G-CSF. The patient presented with a continuous fever and had a huge liver mass in the right lobe with portal vein tumor thrombus (PVTT) in the right first branch. He had marked granulocytosis, and his serum level of G-CSF was elevated. A complete curative liver resection was performed after preoperative radiotherapy to PVTT. The pathological findings of the resected specimen revealed poorly/moderately differentiated HCC, and immunohistochemical staining of G-CSF was negative the first time it was tested, but the second time, it was positive in the cytoplasm of other tumor cells of HCC. Only a few cases of G-CSF-producing HCC have been reported, and they resulted in rapid tumor growth, metastases, and poor prognosis. In our case with PVTT, there was no liver recurrence, although multiple lung metastases occurred at 8 months after curative resection. We should consider G-CSF-producing HCC and diagnose promptly when encountering liver tumor patients with leukocytosis, and we should perform multimodal treatment including radiation, radical surgery, and chemotherapy.
Literatur
1.
Zurück zum Zitat Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28–35CrossRefPubMed Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28–35CrossRefPubMed
2.
Zurück zum Zitat Asano S, Urabe A, Okabe T et al (1977) Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 49:845–852PubMed Asano S, Urabe A, Okabe T et al (1977) Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 49:845–852PubMed
3.
Zurück zum Zitat Iwasa K, Noguchi M, Mor K et al (1995) Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): report of a case. Surg Today 25:158–160CrossRefPubMed Iwasa K, Noguchi M, Mor K et al (1995) Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): report of a case. Surg Today 25:158–160CrossRefPubMed
4.
Zurück zum Zitat Ito N, Matsuda T, Kakehi Y et al (1990) Bladder cancer producing granulocyte colony-stimulating factor. N Engl J Med 323:1709–1710PubMed Ito N, Matsuda T, Kakehi Y et al (1990) Bladder cancer producing granulocyte colony-stimulating factor. N Engl J Med 323:1709–1710PubMed
5.
Zurück zum Zitat Furihata M, Sonobe H, Ohtsuki Y et al (1999) An immunohistochemical study on a case of granulocyte-colony stimulating factor-producing gall-bladder carcinoma. Pathol Int 49:1010–1013CrossRefPubMed Furihata M, Sonobe H, Ohtsuki Y et al (1999) An immunohistochemical study on a case of granulocyte-colony stimulating factor-producing gall-bladder carcinoma. Pathol Int 49:1010–1013CrossRefPubMed
6.
Zurück zum Zitat Endo K, Kohnoe S, Okamura T et al (2005) Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor. Gastric Cancer 8:173–177CrossRefPubMed Endo K, Kohnoe S, Okamura T et al (2005) Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor. Gastric Cancer 8:173–177CrossRefPubMed
7.
Zurück zum Zitat Kamiyama T, Nakanishi K, Yokoo H et al (2007) Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol 12:363–368CrossRefPubMed Kamiyama T, Nakanishi K, Yokoo H et al (2007) Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol 12:363–368CrossRefPubMed
8.
Zurück zum Zitat Ueno M, Seferynska I, Beckman B et al (1989) Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia. Am J Physiol 257:C743–C749CrossRefPubMed Ueno M, Seferynska I, Beckman B et al (1989) Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia. Am J Physiol 257:C743–C749CrossRefPubMed
9.
Zurück zum Zitat Tani K, Ozawa K, Ogura H et al (1990) Expression of granulocyte and granulocyte-macrophage colony-stimulating factors by human non-hematopoietic tumor cells. Growth Factors 3:325–331CrossRefPubMed Tani K, Ozawa K, Ogura H et al (1990) Expression of granulocyte and granulocyte-macrophage colony-stimulating factors by human non-hematopoietic tumor cells. Growth Factors 3:325–331CrossRefPubMed
10.
Zurück zum Zitat Aita K, Seki K (2006) Carcinosarcoma of the liver producing granulocyte-colony stimulating factor. Pathol Int 56:413–419CrossRefPubMed Aita K, Seki K (2006) Carcinosarcoma of the liver producing granulocyte-colony stimulating factor. Pathol Int 56:413–419CrossRefPubMed
11.
Zurück zum Zitat Joshita S, Nakazawa K, Koike S et al (2010) A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry. J Korean Med Sci 25:476–480CrossRefPubMedPubMedCentral Joshita S, Nakazawa K, Koike S et al (2010) A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry. J Korean Med Sci 25:476–480CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Berdel WE, Danhauser-Riedl S, Steinhauser G et al (1989) Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73:80–83PubMed Berdel WE, Danhauser-Riedl S, Steinhauser G et al (1989) Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73:80–83PubMed
13.
Zurück zum Zitat Yamamoto S, Takashima S, Ogawa H et al (1999) Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma. J Gastroenterol 34:640–644CrossRefPubMed Yamamoto S, Takashima S, Ogawa H et al (1999) Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma. J Gastroenterol 34:640–644CrossRefPubMed
14.
Zurück zum Zitat Ito T, Okubo K, Shiomi M et al (2012) [A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur–uracil.]. Nihon Shokakibyo Gakkai Zasshi 109:2088–2096PubMed Ito T, Okubo K, Shiomi M et al (2012) [A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur–uracil.]. Nihon Shokakibyo Gakkai Zasshi 109:2088–2096PubMed
15.
Zurück zum Zitat Amano H, Itamoto T, Emoto K et al (2005) Granulocyte colony-stimulating factor-producing combined hepatocellular/cholangiocellular carcinoma with sarcomatous change. J Gastroenterol 40:1158–1159CrossRefPubMed Amano H, Itamoto T, Emoto K et al (2005) Granulocyte colony-stimulating factor-producing combined hepatocellular/cholangiocellular carcinoma with sarcomatous change. J Gastroenterol 40:1158–1159CrossRefPubMed
16.
Zurück zum Zitat Araki K, Kishihara F, Takahashi K et al (2007) Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int 27:716–721CrossRefPubMed Araki K, Kishihara F, Takahashi K et al (2007) Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int 27:716–721CrossRefPubMed
17.
Zurück zum Zitat Kohno M, Shirabe K, Mano Y et al (2013) Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case. Surg Today 43:439–445CrossRefPubMed Kohno M, Shirabe K, Mano Y et al (2013) Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case. Surg Today 43:439–445CrossRefPubMed
18.
Zurück zum Zitat Snyder RA, Liu E, Merchant NB (2012) Granulocyte colony stimulating factor secreting hepatocellular carcinoma. Am Surg 78:821–822PubMed Snyder RA, Liu E, Merchant NB (2012) Granulocyte colony stimulating factor secreting hepatocellular carcinoma. Am Surg 78:821–822PubMed
19.
Zurück zum Zitat Nagata H, Komatsu S, Takaki W et al (2016) Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes. World J Clin Oncol 7:380–386CrossRefPubMedPubMedCentral Nagata H, Komatsu S, Takaki W et al (2016) Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes. World J Clin Oncol 7:380–386CrossRefPubMedPubMedCentral
Metadaten
Titel
Hepatocellular carcinoma producing granulocyte colony-stimulating factor: diagnosis and treatment
verfasst von
Yuzuru Sakamoto
Toshiya Kamiyama
Hideki Yokoo
Shingo Shimada
Takahiro Einama
Kenji Wakayama
Tatsuya Orimo
Hirofumi Kamachi
Tomoaki Naka
Tomoko Mitsuhashi
Akinobu Taketomi
Publikationsdatum
24.09.2018
Verlag
Springer Japan
Erschienen in
International Cancer Conference Journal / Ausgabe 1/2019
Elektronische ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-0346-x

Weitere Artikel der Ausgabe 1/2019

International Cancer Conference Journal 1/2019 Zur Ausgabe

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.